Conquering Cancers that Hit Below the Belt
Gregory Sfakianos, MD Gynecologic Oncologist Disclosures
None Objectives
• Define gynecologic cancers • Risk factors • Diagnosis • Treatment • Prognosis Gynecologic Oncologist
• Physicians – Surgeons • Perform surgery to manage cancers of the female pelvis. – Oncologists • Chemotherapy – Administer chemotherapy – Manage side effects Gynecology Oncology
• Gynecologic cancers attack a woman's reproductive organs – cervix, uterus, ovaries, fallopian tube, vagina and vulva.
• 105,890 women will be diagnosed this year
• 38,890 women will die this year
Prevalence of Gynecologic Cancers
Estimated New Cases
Others 5,670 7% Cervix 11,070 14% Uterine 40,100 Ovary 51% 21,650 28%
Uterine cancer is the most common.
American Cancer Society. Cancer Facts & Figures 2008. Atlanta, GA: American Cancer Society; 2008. 9 Gynecologic Cancer Deaths
Estimated Cancer Deaths
Others 1,630 6% Cervix 3,870 Uterine 14% 7,470 26%
Ovary 15,520 54%
Ovarian cancer is the most lethal.
American Cancer Society. Cancer Facts & Figures 2008. Atlanta, GA: American Cancer Society; 2008. 10 Gynecologic Cancer Cervical Cancer
• Cancer of the opening to the uterus (womb).
• Most common cause of cancer death in the world where Pap tests are not available
• Easiest gynecologic cancer to prevent through screening and early vaccination Cervical Cancer
• Rare in the U.S. secondary to Pap tests – Screening detects pre-cancerous changes – Approximately 11,270 cases are diagnosed yearly. • Caused by the Human Papilloma Virus – Very few HPV infections actually lead to cervical cancer – Most HPV infections are asymptomatic HPV
• A viral infection that can cause: HPV
• A viral infection that can cause: – Common warts HPV
• A viral infection that can cause: – Common warts – Genital warts HPV
• A viral infection that can cause: – Common warts – Genital warts – Precancerous lesions HPV
• A viral infection that can cause: – Common warts – Genital warts – Precancerous lesions – Cancer Common Infection
Infected with HPV Infection Is Sexually Transmitted Many Types of HPVs
Different HPVs–Different Infections Harmless No warts or cancer Warts-Linked Genital warts Cancer-Linked Most clear up Some persist, but no abnormalities in cervix Some persist, some abnormalities in cervix A few persist and progress to cervical cancer Cervical Cancer Risk Factors
• Women who have ever had sex • More than one sexual partner • Women whose partner (s) has had more than one sexual partner • Women who do not have Pap smears Cervical Cancer Risk Factors
• Immuno- suppressed patients including those who: – Use steroid medications on a regular basis – Organ transplant recipients – Are undergoing chemotherapy – Are infected with HIV
• Women who smoke. – Smoking all by itself increases the risk of HPV infection and cervical precancer lesions, and doubles the risk of getting cervical cancer Abnormal Pap test – How common is it?
10,000 cancers
300,000 HSIL (High-Grade precancerous lesions
1.25 million LSIL (Low-Grade precancerous lesions)
2-3 million ASC (Atypical Squamous Lesions
50-60 million women screened Abnormal Pap test- What next?
• Colposcopy- – Evaluation of the cervix with a microscope on a stand – Biopsies • Negative biopsy- repeat Pap smear in 6 months • Precancerous changes- larger cervical biopsy What are the symptoms of cervical cancer? • Abnormal bleeding – Between periods – With intercourse – After menopause • Unusual vaginal discharge • Other symptoms – Leg pain – Pelvic pain – Bleeding from the rectum or bladder • Some women have no symptoms Cervical Cancer Treatment
• Surgery – Simple hysterectomy vs. Radical hysterectomy
• Radiation and Chemotherapy Cervical cancer: survival by stage
FIGO Stage 5-Year Survival
Stage I 81-96%
Stage II 65-87%
Stage III 35-50%
Stage IV 15-20% Uterine Cancer
• Fourth most common cancer affecting women
• Most common gynecologic malignancy
• Usually diagnosed early secondary to easy recognizable symptoms Uterine Cancer Risk Factors
• Obesity • Unopposed estrogen • Diabetes • Hypertension • Tamoxifen use • Nulliparity • Late menopause • Genetic risk factors Uterine Cancer Symptoms
• Postmenopausal bleeding
• Abnormal uterine bleeding
• Abnormal discharge
• Pelvic pressure Uterine Cancer Diagnosis
• Endometrial sampling – Office- endometrial biopsy – Operating room- D&C
• Hysterectomy Endometrial Cancer Treatment
• Surgery – Total Hysterectomy – Surgical staging • Hormonal therapy • Radiation • Chemotherapy Uterine cancer: survival by stage
FIGO Stage 5-Year Survival
Stage I 85- 91%
Stage II 74- 83%
Stage III 50- 66%
Stage IV 20- 26% Ovarian Cancer Ovarian Cancer
• 5th deadliest cancer in women • Majority of women diagnosed with advanced disease • Good initial response rates to therapy • Most patients develop recurrence and die within a few years Ovarian Cancer: Risk Factors • Increased Risk • Decreased Risk – Long ovulation history1 – Prophylactic surgery4,5 – Nulliparity2 – Oral contraceptive use4 – Talc3 – Increased parity4 – Family history of – Hysterectomy4 breast/ovarian cancer4 – Tubal ligation4 – Dietary factors4
1. American Cancer Society. Cancer Facts & Figures 2008. Atlanta, GA: American Cancer Society; 2008. 2. National Cancer Institute. Genetics of Breast and Ovarian Cancer. Revised 12/23/2008. 3. American Cancer Society. What Are the Risk Factors for Ovarian Cancer? Revised 01/19/2008. 4. Gates MA, Tworoger SS, Terry KL, et al. Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(9):2436-2444. 5. Fatouros M, Baltoyiannis G, Roukos DH. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations. Ann Surg Oncol. 2008;15(1):21-33. 37 Ovarian Cancer Symptoms
• Bloating, • Increased abdominal girth • Abdominal discomfort • Early satiety • Urinary urgency or frequency • New onset constipation and/ or diarrhea Ovarian Cancer Diagnosis
• Paracentesis – Fluid removed from the abdomen
• Biopsy of mass
• Surgery Ovarian Cancer
• Treatment – Surgical staging – Maximal surgical debulking – Chemotherapy • 6 cycles of platinum based chemotherapy • Neoadjuvant chemotherapy – interval surgical debulking • Good option for poor surgical candidates Ovarian cancer: survival by stage
FIGO Stage 5-Year Survival
Stage I 83- 90%
Stage II 65- 71%
Stage III 20- 47%
Stage IV 10- 20% Questions?